Provider review
Metabolyz review
Publishes the microdose ladder in milligrams and no price for any GLP-1.
It is the reverse of the usual gap: the dose is knowable and the cost is not, while its peptide catalog is priced openly.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
Metabolyz
No GLP-1 price published at any tier
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1300/mo across 242 of 373
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Almost every provider here publishes a price and hides the dose. Metabolyz does the opposite — its microdose page carries an actual milligram ladder, which is rarer and arguably more useful, and then declines to price any GLP-1 product at all. Semaglutide, tirzepatide and the microdose each say only that they are available by consultation, while the separate peptide catalog on the same site carries per-molecule figures. So the site can publish a price and chooses not to on the products it leads with. Unreplaced template placeholder text ships on the treatment pages in production.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to see the intended microdose ladder in milligrams before you talk to anyone
- You want lifestyle coaching positioned as a named part of the program rather than an add-on
- You are comfortable entering an eligibility funnel without any price in hand
Look elsewhere if
- You want any GLP-1 price at all before starting — none is published at any tier
- You want a finished site: placeholder template text ships on the treatment pages
- You want a named pharmacy, a compounding designation, or a list of states served
What it actually costs
Price as published
Pricing not published for any GLP-1 product. Semaglutide, tirzepatide and the named GLP-1 Microdose protocol all say only that they are available by consultation, and the homepage carries no pricing section. The microdose page DOES publish its intended dose ladder — 0.10 mg, 0.15 mg and 0.25 mg — so a reader can see the doses and nothing about what they cost. The only prices on the site are on the separate peptide catalog
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
52 of the 373 programs we track price a small dose this way. The row records that no price is published for any GLP-1 product at any tier — all three treatment pages say only that they are available by consultation — while the separate peptide catalog on the same site carries per-molecule figures. It also records that the microdose page does publish an intended dose ladder in milligrams, which is the reverse of the usual gap: the dose is knowable and the price is not.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The microdose page publishes an actual dose ladder in milligrams — 0.10 mg, 0.15 mg and 0.25 mg — which almost nothing else here does for a microdose protocol
- The peptide catalog carries real per-molecule from-prices organized by clinical goal, so the site is capable of publishing a price when it wants to
- The terms of use are unusually direct that the operator is a technology platform and not a healthcare provider
- Positions coaching in nutrition, movement and lifestyle as a named pillar alongside medication, with structured check-ins described
- Runs separate eligibility funnels for GLP-1 and for peptides, so the two catalogs are not conflated
- The legal entity is named plainly in the terms of use
Pharmacy, labs and oversight
Metabolyz does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Metabolyz publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Metabolyz is operated by a company that states in its terms that it owns the site and acts solely as a technology platform, explicitly disclaiming that it practices medicine, provides clinical care, or prepares or dispenses medications. It sells semaglutide, tirzepatide and a GLP-1 Microdose protocol, plus a separate peptide catalog with its own eligibility quiz. The pitch is GLP-1 therapy paired with lifestyle coaching in nutrition and movement rather than medication alone. No pharmacy is named, no compounding designation is stated, and no list of states served is published.
The honest cons
Publishes no price for any GLP-1 product at any tier — semaglutide, tirzepatide and the microdose all say only "available by consultation" — while the peptide catalog on the same site carries per-molecule prices. It can publish a price and chooses not to on the products it leads with
- Unreplaced template placeholder text ships in production on the GLP-1 treatment pages
- The site is a near-identical template sibling of another brand here — the same application bundle, the same treatment data structure, the same taglines — under a different operating company, and neither brand discloses the relationship
- The site's own code carries an unrendered microdose price that the site never shows, so the number exists internally and is withheld from the reader
- No pharmacy named, no 503A/503B designation, and no list of states served anywhere on the site
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Metabolyz is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#63 of 373
Ordered with the companies that pay us first, and Metabolyz is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Microdosing semaglutide
- Microdose & reconstitution calculator
- The true annual cost of a plan
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
Care Bare Rx
From $199/mo*
- Vs median
- $30/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Care Bare Rx review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.